SCHEMBL26645705

SCHEMBL26645705

CC(C)(C)OC(=O)N1CCn2nc(-c3ccc(C(F)(F)F)cc3)c(-c3ccncc3)c2C1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 7/20 0.46
CSNK1E P49674 7/20 0.46
MAPT P10636 1/20 0.46
GPR119 Q8TDV5 2/20 0.43
HDAC4 P56524 1/20 0.39
MAPK14 Q16539 2/20 0.39
SRC P12931 1/20 0.39
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
CTSS P25774 2/20 0.38
CKS1B P61024 2/20 0.38
SKP1 P63208 2/20 0.38
SKP2 Q13309 2/20 0.38
MAPK11 Q15759 1/20 0.38
ENPP2 Q13822 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645681 0.91 CSNK1E (0.48) CSNK1DCSNK1EGPR119MAPK14CKS1B
SCHEMBL26645250 0.90 CSNK1D (0.48) CSNK1DCSNK1EGPR119CKS1BSKP1
SCHEMBL26645466 0.90 CSNK1D (0.49) CSNK1DCSNK1EGPR119CKS1BSKP1
SCHEMBL26645522 0.90 CSNK1E (0.44) CSNK1DCSNK1EMAPTGPR119CKS1B
SCHEMBL26645019 0.89 CSNK1D (0.47) CSNK1DCSNK1EGPR119MAPK14CKS1B
SCHEMBL26645150 0.89 CSNK1E (0.44) CSNK1DCSNK1EMAPTGPR119HDAC4
SCHEMBL26645342 0.89 CSNK1E (0.45) CSNK1DCSNK1EMAPTGPR119CKS1B
SCHEMBL26645412 0.88 CSNK1E (0.42) CSNK1DCSNK1EMAPTGPR119ENPP2
SCHEMBL26645399 0.88 CSNK1E (0.46) CSNK1DCSNK1EMAPTGPR119SRC
SCHEMBL26645053 0.87 CSNK1D (0.46) CSNK1DCSNK1EGPR119CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO disclosed